User:Mr. Ibrahem/Telmisartan

Telmisartan, sold under the trade name Micardis among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination telmisartan/hydrochlorothiazide and telmisartan/amlodipine.

Common side effects include upper respiratory tract infections, diarrhea, and back pain. Serious side effects may include kidney problems, low blood pressure, and angioedema. Use in pregnancy may harm the baby and use when breastfeeding is not recommended. It is an angiotensin II receptor antagonist and works by blocking the effects of angiotensin II.

Telmisartan was patented in 1991 and came into medical use in 1999. It is available as a generic medication. A month supply in the United Kingdom costs the NHS less than £2 as of 2019. In the United States the wholesale cost of this amount is about US$10. In 2017, it was the 249th most commonly prescribed medication in the United States, with more than one million prescriptions.